+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Translational Medicine"

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024 - Product Thumbnail Image

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2024

  • Report
  • September 2024
  • 250 Days
  • Global
From
Polyclonal Antibodies Market Report 2025 - Product Thumbnail Image

Polyclonal Antibodies Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Emerging Medical Technologies Spotlight - Product Thumbnail Image

Emerging Medical Technologies Spotlight

  • Newsletter
  • March 2025
  • Global
From
AP-101 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

AP-101 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
MIN-102 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

MIN-102 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
From
From
Biomarkers in Drug Development - Product Thumbnail Image

Biomarkers in Drug Development

  • Training
  • 60 Minutes
  • Global
From
Loading Indicator

Translational Medicine is a field of biotechnology that focuses on the development of treatments and therapies for diseases and medical conditions. It involves the translation of basic research findings into clinical applications, such as the development of new drugs, diagnostics, and medical devices. Translational Medicine also involves the development of new methods for clinical trials and the evaluation of existing treatments. The Translational Medicine market is driven by the need for new treatments and therapies for diseases and medical conditions. It is also driven by the need for improved diagnostics and medical devices. The market is expected to grow as new treatments and therapies are developed and as existing treatments are evaluated. Some companies in the Translational Medicine market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more